Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,684 | 4,151 | 8,688 | 10,505 | 12,510 |
| TOTAL | $4,952 | $4,455 | $8,754 | $10,663 | $12,760 |
| Non-Current Assets | |||||
| PPE Net | 1 | 2 | 3 | 4 | 5 |
| Other Non-Current Assets | 916 | 916 | 0 | 0 | 0 |
| TOTAL | $917 | $918 | $3 | $4 | $5 |
| Total Assets | $5,869 | $5,373 | $8,757 | $10,667 | $12,765 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,457 | 1,657 | 1,880 | 1,815 | 1,602 |
| Accrued Expenses | 1,275 | 1,179 | 779 | 494 | 684 |
| TOTAL | $2,732 | $2,836 | $2,659 | $2,309 | $2,286 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,446 | 916 | 0 | 0 | 0 |
| TOTAL | $3,446 | $916 | $N/A | $N/A | $N/A |
| Total Liabilities | $6,178 | $3,752 | $2,659 | $2,309 | $2,286 |
| Shareholders' Equity | |||||
| Common Shares | 33 | 27 | 26 | 25 | 24 |
| Retained earnings | -327,638 | -325,439 | -319,529 | -315,550 | -311,381 |
| Other shareholders' equity | -380 | -380 | -380 | -380 | -380 |
| TOTAL | $-309 | $1,621 | $6,098 | $8,358 | $10,479 |
| Total Liabilities And Equity | $5,869 | $5,373 | $8,757 | $10,667 | $12,765 |